Breast Cancer Clinical Trial

RISE – Reduce Sitting Time Among Breast Cancer Survivors

Summary

This 3-month study will test whether a program to reduce sitting time, for breast cancer survivors experiencing some physical limitations, can improve their physical function and other important aspects of quality of life.

View Full Description

Full Description

Many cancer survivors experience long-term physical problems following their cancer treatments and can often seem much older than same age peers who were never treated for cancer. This is known as accelerated aging. One way to improve accelerated aging is to increase moderate to vigorous intensity exercise; however, for many cancer survivors, especially those with physical limitations, increasing exercise levels is not possible. Another potential way to improve accelerated aging may be to decrease the amount of time spent sitting. Long periods of sitting are related to many physical and health problems. Cancer survivors spend more than 9 hours a day sitting and often increase the amount they sit after their cancer treatments. This study could help identify realistic intervention targets for many cancer survivors and be used to guide recommendations for improving physical function and quality of life after cancer.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Breast cancer survivors (stages I-IV) at least 1 year post active treatment (e.g., chemotherapy, radiotherapy)
Breast cancer was treated with chemotherapy, radiation, immunotherapy, and/or endocrine therapy
self-report difficulties with physical function
self-report low levels of moderate to vigorous physical activity
self-report high levels of sitting time

Exclusion Criteria:

medical condition that interferes with ability to safely stand or stay balanced
other cancer diagnoses that occurred after their breast cancer diagnosis
Stage IV breast cancer with brain metastases or less than 12 months life-expectancy
unable to commit to a 3-month study

Study is for people with:

Breast Cancer

Estimated Enrollment:

21

Study ID:

NCT05260723

Recruitment Status:

Active, not recruiting

Sponsor:

University of California, San Diego

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Moores UCSD Cancer Center
La Jolla California, 92093, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

21

Study ID:

NCT05260723

Recruitment Status:

Active, not recruiting

Sponsor:


University of California, San Diego

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.